Medirom Healthcare Technologies Inc. (NASDAQ:MRM – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totaling 2,779 shares, a decline of 78.6% from the September 15th total of 13,001 shares. Based on an average daily volume of 20,358 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are sold short.
Medirom Healthcare Technologies Trading Down 2.9%
NASDAQ MRM traded down $0.02 during trading hours on Monday, reaching $0.54. 2,615 shares of the stock traded hands, compared to its average volume of 22,743. The stock has a 50 day simple moving average of $0.84 and a two-hundred day simple moving average of $1.00. Medirom Healthcare Technologies has a 1 year low of $0.53 and a 1 year high of $2.85.
Analysts Set New Price Targets
Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Medirom Healthcare Technologies in a research note on Tuesday, August 25th. One investment analyst has rated the stock with a Sell rating. According to MarketBeat, Medirom Healthcare Technologies has a consensus rating of “Sell”.
Medirom Healthcare Technologies Company Profile
Medirom Healthcare Technologies Inc is a Japan-based healthcare and wellness company that provides relaxation, body-care and preventive-health services. Its core business operates under the Re.Ra.Ku brand, a network of studios offering services such as relaxation treatments, stretching and other wellness programs intended to support customers’ physical well-being.
The company also develops digital preventive-healthcare products and services. These initiatives include wearable technology designed to collect health-related data and support ongoing wellness management, including the MOTHER Bracelet, a device marketed as a low-maintenance activity and health-monitoring wearable.
Medirom serves customers primarily in Japan through its physical locations and technology-based healthcare offerings.
See Also
- Five stocks we like better than Medirom Healthcare Technologies
- Salesforce Just Got a Rare Double Upgrade—What Changed?
- OpenAI’s Revenue Scare Could Be a Big Opportunity for Investors
- China Still Dominates Rare Earths—These 3 U.S. Companies Could Benefit
- 3 REITs That May Win in a Higher Interest Rate Environment
Receive News & Ratings for Medirom Healthcare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medirom Healthcare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
